{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.201","meta":{"versionId":"5","lastUpdated":"2021-05-21T01:01:02.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.201","version":"20210521","name":"Tagraxofusp Injectable","status":"active","date":"2021-05-21T01:01:02-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"2109059","display":"1 ML tagraxofusp-erzs 1 MG/ML Injection"}]}]},"expansion":{"identifier":"urn:uuid:1b794ec1-2c12-4932-9344-7429a2a45d89","timestamp":"2022-06-10T12:25:59-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"2109059","display":"1 ML tagraxofusp-erzs 1 MG/ML Injection"}]}}